• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌中 CXCR2 大分子复合物:肿瘤生长中的潜在治疗靶点。

CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growth.

机构信息

Department of Biochemistry and Molecular Biology, Wayne State University School of Medicine, Detroit, MI.

出版信息

Transl Oncol. 2013 Apr;6(2):216-25. doi: 10.1593/tlo.13133. Epub 2013 Apr 1.

DOI:10.1593/tlo.13133
PMID:23544174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3610555/
Abstract

The signaling mediated by the chemokine receptor CXC chemokine receptor 2 (CXCR2) plays an important role in promoting the progression of many cancers, including pancreatic cancer, one of the most lethal human malignancies. CXCR2 possesses a consensus PSD-95/DlgA/ZO-1 (PDZ) motif at its carboxyl termini, which might interact with potential PDZ scaffold/adaptor proteins. We have previously reported that CXCR2 PDZ motif-mediated protein interaction is an important regulator for neutrophil functions. Here, using a series of biochemical assays, we demonstrate that CXCR2 is physically coupled to its downstream effector phospholipase C-β3 (PLC-β3) that is mediated by PDZ scaffold protein Na(+)/H(+) exchange regulatory factor 1 (NHERF1) into a macromolecular signaling complex both in vitro and in pancreatic cancer cells. We also observe that disrupting the CXCR2 complex, by gene delivery or peptide delivery of exogenous CXCR2 C-tail, significantly inhibits the biologic functions of pancreatic cancer cells (i.e., proliferation and invasion) in a PDZ motif-dependent manner. In addition, using a human pancreatic tumor xenograft model, we show that gene delivery of CXCR2 C-tail sequence (containing the PDZ motif) by adeno-associated virus type 2 viral vector potently suppresses human pancreatic tumor growth in immunodeficient mice. In summary, our results suggest the existence of a physical and functional coupling of CXCR2 and PLC-β3 mediated through NHERF1, forming a macromolecular complex that is critical for efficient and specific CXCR2 signaling in pancreatic cancer progression. Disrupting this CXCR2 complex could represent a novel and effective treatment strategy against pancreatic cancer.

摘要

趋化因子受体 CXC 趋化因子受体 2(CXCR2)介导的信号转导在促进许多癌症的进展中起着重要作用,包括胰腺癌,这是人类最致命的恶性肿瘤之一。CXCR2 在其羧基末端具有一个 PDZ 基序(PSD-95/DlgA/ZO-1)共识基序,该基序可能与潜在的 PDZ 支架/衔接蛋白相互作用。我们之前报道过,CXCR2 PDZ 基序介导的蛋白质相互作用是调节中性粒细胞功能的重要因素。在这里,我们使用一系列生化测定法证明,CXCR2 通过 PDZ 支架蛋白 Na+/H+交换调节因子 1(NHERF1)与下游效应物磷脂酶 C-β3(PLC-β3)物理偶联,形成一个在体外和胰腺癌细胞中的大分子信号复合物。我们还观察到,通过基因传递或外源性 CXCR2 C 端肽的传递破坏 CXCR2 复合物,以 PDZ 基序依赖性方式显著抑制胰腺癌细胞的生物学功能(即增殖和侵袭)。此外,我们使用人胰腺肿瘤异种移植模型表明,腺相关病毒 2 病毒载体的 CXCR2 C 端序列(包含 PDZ 基序)的基因传递可有力地抑制免疫缺陷小鼠中的人胰腺肿瘤生长。总之,我们的结果表明,通过 NHERF1 介导 CXCR2 和 PLC-β3 之间存在物理和功能偶联,形成一个大分子复合物,对于 CXCR2 在胰腺癌细胞进展中的有效和特异性信号转导至关重要。破坏这种 CXCR2 复合物可能代表针对胰腺癌的一种新的有效治疗策略。

相似文献

1
CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growth.胰腺癌中 CXCR2 大分子复合物:肿瘤生长中的潜在治疗靶点。
Transl Oncol. 2013 Apr;6(2):216-25. doi: 10.1593/tlo.13133. Epub 2013 Apr 1.
2
A critical role of CXCR2 PDZ-mediated interactions in endothelial progenitor cell homing and angiogenesis.CXCR2的PDZ介导的相互作用在内皮祖细胞归巢和血管生成中的关键作用。
Stem Cell Res. 2015 Mar;14(2):133-43. doi: 10.1016/j.scr.2014.12.001. Epub 2014 Dec 30.
3
A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseases.趋化因子受体 CXCR2 大分子复合物调节炎症性疾病中的中性粒细胞功能。
J Biol Chem. 2012 Feb 17;287(8):5744-55. doi: 10.1074/jbc.M111.315762. Epub 2011 Dec 27.
4
Crystallographic analysis of NHERF1-PLCβ3 interaction provides structural basis for CXCR2 signaling in pancreatic cancer.晶体学分析表明 NHERF1-PLCβ3 相互作用为胰腺癌中 CXCR2 信号提供结构基础。
Biochem Biophys Res Commun. 2014 Apr 4;446(2):638-43. doi: 10.1016/j.bbrc.2014.03.028. Epub 2014 Mar 15.
5
Structural basis of PDZ-mediated chemokine receptor CXCR2 scaffolding by guanine nucleotide exchange factor PDZ-RhoGEF.鸟嘌呤核苷酸交换因子PDZ-RhoGEF介导趋化因子受体CXCR2支架形成的PDZ结构基础
Biochem Biophys Res Commun. 2017 Apr 1;485(2):529-534. doi: 10.1016/j.bbrc.2017.02.010. Epub 2017 Feb 6.
6
Crystal structure of the NHERF1 PDZ2 domain in complex with the chemokine receptor CXCR2 reveals probable modes of PDZ2 dimerization.NHERF1 PDZ2 结构域与趋化因子受体 CXCR2 复合物的晶体结构揭示了 PDZ2 二聚体可能的模式。
Biochem Biophys Res Commun. 2014 May 30;448(2):169-74. doi: 10.1016/j.bbrc.2014.04.085. Epub 2014 Apr 24.
7
In vitro analysis of PDZ-dependent CFTR macromolecular signaling complexes.PDZ 依赖性囊性纤维化跨膜传导调节因子(CFTR)大分子信号复合物的体外分析
J Vis Exp. 2012 Aug 13(66):4091. doi: 10.3791/4091.
8
Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.癌细胞中表达的趋化因子达菲抗原受体(DARC)通过抑制人胰腺导管腺癌中的CXCR2信号传导来抑制肿瘤进展。
Cytokine. 2017 Jul;95:12-21. doi: 10.1016/j.cyto.2017.02.007. Epub 2017 Feb 20.
9
Structural insights into neutrophilic migration revealed by the crystal structure of the chemokine receptor CXCR2 in complex with the first PDZ domain of NHERF1.通过趋化因子受体 CXCR2 与 NHERF1 的第一 PDZ 结构域复合物的晶体结构揭示嗜中性粒细胞迁移的结构见解。
PLoS One. 2013 Oct 2;8(10):e76219. doi: 10.1371/journal.pone.0076219. eCollection 2013.
10
The carboxyl-terminal PDZ ligand motif of chemokine receptor CXCR2 modulates post-endocytic sorting and cellular chemotaxis.趋化因子受体CXCR2的羧基末端PDZ配体基序调节内吞后分选和细胞趋化性。
J Biol Chem. 2008 Nov 7;283(45):30868-78. doi: 10.1074/jbc.M804054200. Epub 2008 Aug 27.

引用本文的文献

1
Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway.脯氨酰羟化酶 2 通过 NF-κB 信号通路抑制结直肠癌细胞的糖酵解活性。
Int J Oncol. 2024 Jan;64(1). doi: 10.3892/ijo.2023.5590. Epub 2023 Nov 17.
2
The roles of phospholipase C-β related signals in the proliferation, metastasis and angiogenesis of malignant tumors, and the corresponding protective measures.磷脂酶C-β相关信号在恶性肿瘤增殖、转移及血管生成中的作用及相应的防护措施。
Front Oncol. 2023 Jul 28;13:1231875. doi: 10.3389/fonc.2023.1231875. eCollection 2023.
3
CXCL5 knockdown attenuated gemcitabine resistance of pancreatic cancer through regulation of cancer cells and tumour stroma.CXCL5基因敲低通过调节癌细胞和肿瘤基质减弱胰腺癌对吉西他滨的耐药性。
Am J Transl Res. 2023 Apr 15;15(4):2676-2689. eCollection 2023.
4
Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer.小分子 CXCR2 和 CXCR1 拮抗剂抑制胰腺癌的肿瘤生长、血管生成和转移。
Cancer Lett. 2023 Jun 1;563:216185. doi: 10.1016/j.canlet.2023.216185. Epub 2023 Apr 14.
5
Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases.肽靶向 PDZ 依赖性相互作用作为免疫相关疾病的药理学干预。
Molecules. 2021 Oct 21;26(21):6367. doi: 10.3390/molecules26216367.
6
Chemokine Receptor 2 (CXCR2) Gene Polymorphisms and Their Association with the Risk of Developing Peri-Implantitis in Chinese Han Population.趋化因子受体2(CXCR2)基因多态性及其与中国汉族人群种植体周围炎发生风险的关联
J Inflamm Res. 2021 Apr 23;14:1625-1631. doi: 10.2147/JIR.S304261. eCollection 2021.
7
Intermittent hypoxia-induced downregulation of microRNA-320b promotes lung cancer tumorigenesis by increasing CDT1 via USP37.间歇性低氧诱导的微小RNA-320b下调通过USP37增加CDT1促进肺癌肿瘤发生。
Mol Ther Nucleic Acids. 2021 Jan 1;24:528-541. doi: 10.1016/j.omtn.2020.12.023. eCollection 2021 Jun 4.
8
Reduction of miR-744 delivered by NSCLC cell-derived extracellular vesicles upregulates SUV39H1 to promote NSCLC progression via activation of the Smad9/BMP9 axis.非小细胞肺癌(NSCLC)细胞衍生的细胞外囊泡所携带的miR-744减少,通过激活Smad9/BMP9轴上调SUV39H1,从而促进NSCLC进展。
J Transl Med. 2021 Jan 20;19(1):37. doi: 10.1186/s12967-020-02654-9.
9
Host Cxcr2-Dependent Regulation of Pancreatic Cancer Growth, Angiogenesis, and Metastasis.宿主 Cxcr2 依赖性调控胰腺癌生长、血管生成和转移。
Am J Pathol. 2021 Apr;191(4):759-771. doi: 10.1016/j.ajpath.2021.01.002. Epub 2021 Jan 14.
10
Methylation-Mediated Silencing of MicroRNA-497 Promotes Breast Cancer Progression Through Up-Regulation of Mucin1.微小RNA-497的甲基化介导沉默通过上调粘蛋白1促进乳腺癌进展。
Front Oncol. 2020 Oct 23;10:552099. doi: 10.3389/fonc.2020.552099. eCollection 2020.

本文引用的文献

1
In vitro analysis of PDZ-dependent CFTR macromolecular signaling complexes.PDZ 依赖性囊性纤维化跨膜传导调节因子(CFTR)大分子信号复合物的体外分析
J Vis Exp. 2012 Aug 13(66):4091. doi: 10.3791/4091.
2
Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer.Met 受体酪氨酸激酶信号转导诱导胰腺癌中血管生成趋化因子白细胞介素-8/CXCL8 的分泌。
PLoS One. 2012;7(7):e40420. doi: 10.1371/journal.pone.0040420. Epub 2012 Jul 17.
3
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
4
A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseases.趋化因子受体 CXCR2 大分子复合物调节炎症性疾病中的中性粒细胞功能。
J Biol Chem. 2012 Feb 17;287(8):5744-55. doi: 10.1074/jbc.M111.315762. Epub 2011 Dec 27.
5
Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis.了解细胞因子在多形性胶质母细胞瘤发病机制中的作用。
Cancer Lett. 2012 Mar 28;316(2):139-50. doi: 10.1016/j.canlet.2011.11.001. Epub 2011 Nov 7.
6
Molecular targeted approaches for treatment of pancreatic cancer.治疗胰腺癌的分子靶向方法。
Curr Pharm Des. 2011;17(21):2221-38. doi: 10.2174/138161211796957427.
7
Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.CXCL5 的过表达与胰腺癌患者的不良生存相关。
Am J Pathol. 2011 Mar;178(3):1340-9. doi: 10.1016/j.ajpath.2010.11.058.
8
Subtype-specific roles of phospholipase C-β via differential interactions with PDZ domain proteins.磷脂酶C-β通过与PDZ结构域蛋白的差异相互作用发挥的亚型特异性作用。
Adv Enzyme Regul. 2011;51(1):138-51. doi: 10.1016/j.advenzreg.2010.10.004. Epub 2010 Oct 28.
9
Alterations in the proteome of the NHERF1 knockout mouse jejunal brush border membrane vesicles.NHERF1 敲除小鼠空肠刷状缘膜囊泡蛋白质组的改变。
Physiol Genomics. 2010 Nov 15;42A(3):200-10. doi: 10.1152/physiolgenomics.00001.2010. Epub 2010 Aug 24.
10
CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination.CXCR2 信号在病毒诱导的脱髓鞘小鼠模型中保护少突胶质细胞并限制脱髓鞘。
PLoS One. 2010 Jun 28;5(6):e11340. doi: 10.1371/journal.pone.0011340.